| Mr Ray Bauer Vaughters Iii, MD | |
|
526 Richland Ave W, R Bauer Vaughters Iii Md Inc, Aiken, SC 29801 | |
| (803) 648-3130 | |
| (803) 502-1103 |
| Full Name | Mr Ray Bauer Vaughters Iii |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 26 Years |
| Location | 526 Richland Ave W, Aiken, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457327587 | NPI | - | NPPES |
| 228097 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 22809 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allendale County Hospital | Fairfax, SC | Hospital |
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| R. Bauer Vaughters, Iii, Md, Inc. | 7214927441 | 3 |
News Archive
Hopeful that some of the same antiretroviral (ARV) drugs used to treat HIV infection can also prevent it, researchers from the Microbicide Trials Network have enrolled the first participants into a new, large-scale clinical trial testing two approaches of the strategy in women.
Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its panel of inflammation biomarkers will be featured at next week's TEDMED 2012 conference in Washington.
IDRI's drug discovery efforts continue to grow with a recently awarded grant extension of $3.4 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya Parish, Ph.D., IDRI's Vice President of Drug Discovery, and supplements an earlier grant awarded in 2010, for a total of $7.8 million.
Results of an Active Controlled Clinical Simulated Use Study confirm that RMS High-Flo™ Subcutaneous Needle Sets are "safety sets," according to the manufacturer Repro-Med Systems, Inc., (REPR.PK) dba RMS Medical Products of Chester, N.Y. The U.S. Food and Drug Administration (FDA) has reviewed the protocol for the study. The needle sets are now known as RMS High-Flo™ Subcutaneous Safety Needle Sets.
The National Institutes of Health has awarded two five-year grants to Wake Forest Baptist Medical Center worth more than $5 million to prospectively study the effects of a genetic variation in organ donors that appears to contribute to survival of kidneys after transplantation.
› Verified 9 days ago
| Entity Name | R. Bauer Vaughters, Iii, Md, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427175108 PECOS PAC ID: 7214927441 Enrollment ID: O20040518000515 |
News Archive
Hopeful that some of the same antiretroviral (ARV) drugs used to treat HIV infection can also prevent it, researchers from the Microbicide Trials Network have enrolled the first participants into a new, large-scale clinical trial testing two approaches of the strategy in women.
Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its panel of inflammation biomarkers will be featured at next week's TEDMED 2012 conference in Washington.
IDRI's drug discovery efforts continue to grow with a recently awarded grant extension of $3.4 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya Parish, Ph.D., IDRI's Vice President of Drug Discovery, and supplements an earlier grant awarded in 2010, for a total of $7.8 million.
Results of an Active Controlled Clinical Simulated Use Study confirm that RMS High-Flo™ Subcutaneous Needle Sets are "safety sets," according to the manufacturer Repro-Med Systems, Inc., (REPR.PK) dba RMS Medical Products of Chester, N.Y. The U.S. Food and Drug Administration (FDA) has reviewed the protocol for the study. The needle sets are now known as RMS High-Flo™ Subcutaneous Safety Needle Sets.
The National Institutes of Health has awarded two five-year grants to Wake Forest Baptist Medical Center worth more than $5 million to prospectively study the effects of a genetic variation in organ donors that appears to contribute to survival of kidneys after transplantation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ray Bauer Vaughters Iii, MD Po Box 1132, R Bauer Vaughters Iii Md Inc, Aiken, SC 29802-1132 Ph: (803) 648-3130 | Mr Ray Bauer Vaughters Iii, MD 526 Richland Ave W, R Bauer Vaughters Iii Md Inc, Aiken, SC 29801 Ph: (803) 648-3130 |
News Archive
Hopeful that some of the same antiretroviral (ARV) drugs used to treat HIV infection can also prevent it, researchers from the Microbicide Trials Network have enrolled the first participants into a new, large-scale clinical trial testing two approaches of the strategy in women.
Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its panel of inflammation biomarkers will be featured at next week's TEDMED 2012 conference in Washington.
IDRI's drug discovery efforts continue to grow with a recently awarded grant extension of $3.4 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya Parish, Ph.D., IDRI's Vice President of Drug Discovery, and supplements an earlier grant awarded in 2010, for a total of $7.8 million.
Results of an Active Controlled Clinical Simulated Use Study confirm that RMS High-Flo™ Subcutaneous Needle Sets are "safety sets," according to the manufacturer Repro-Med Systems, Inc., (REPR.PK) dba RMS Medical Products of Chester, N.Y. The U.S. Food and Drug Administration (FDA) has reviewed the protocol for the study. The needle sets are now known as RMS High-Flo™ Subcutaneous Safety Needle Sets.
The National Institutes of Health has awarded two five-year grants to Wake Forest Baptist Medical Center worth more than $5 million to prospectively study the effects of a genetic variation in organ donors that appears to contribute to survival of kidneys after transplantation.
› Verified 9 days ago
Kate Barrett Mayes, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 223 Park Ave Se, Aiken, SC 29801 Phone: 803-641-1270 Fax: 803-641-1276 | |
Thomas Mccullough, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 410 University Pkwy Ste 2500, Aiken, SC 29801 Phone: 803-648-7888 Fax: 803-648-3302 | |
Ghulam Murtaza, Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 | |
Janet L Utz, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 137 Miracle Drive, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Keifer Dewayne Richardson, PA-C Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 526 Richland Ave W, Aiken, SC 29801 Phone: 803-648-3130 | |
Dr. Weems R Pennington Iii, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Dr. Frank Joseph Mondschein, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 102 Summerwood Way, Aiken, SC 29803 Phone: 803-649-5300 Fax: 803-649-0056 |